Please login to the form below

Not currently logged in
Email:
Password:

thalidomide

This page shows the latest thalidomide news and features for those working in and with pharma, biotech and healthcare.

Janssen scores another expansion for new Darzalex combination in the US

Janssen scores another expansion for new Darzalex combination in the US

Janssen has been expanding the use of Darzalex with a number of combination therapies, including its recently approved Darzalex, bortezomib, thalidomide and dexamethasone (VTd) combination.

Latest news

  • We've got this! We've got this!

    When I began my career as a ‘lab rat’ in the late 1970s, my older colleagues regaled me with stories of the industry before the thalidomide disaster and how the subsequent

  • Covidian selection Covidian selection

    Remember, for instance, that while the thalidomide tragedy changed our environment and selected for new routines in drug safety, those changes also spread to far greater regulation of manufacturing, marketing and

  • Janssen files new Darzalex combination for multiple myeloma Janssen files new Darzalex combination for multiple myeloma

    J&J has been expanding the use of Darzalex with a number of combination therapies, including its recently approved Darzalex, bortezomib, thalidomide and dexamethasone (VTd) combination.

  • J&J wins another label expansion for Darzalex in Europe J&J wins another label expansion for Darzalex in Europe

    This time round, the newly approved formulation is comprised of anti-CD38 Darzalex (daratumumab) in combination with bortezomib, thalidomide and dexamethasone (VTd),  a triple regimen which is commonly used in the ... We asked ourselves can we improve

  • J&J expands Darzalex use with another first-line FDA approval J&J expands Darzalex use with another first-line FDA approval

    Darzalex (daratumumab)  has been indicated in combination with bortezomib, thalidomide and dexamethasone (VTD), a triple regimen which is commonly used in the treatment of multiple myeloma.

More from news
Approximately 3 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Driving the innovation engine Driving the innovation engine

    It acquired the rights to thalidomide and explored commercialising the drug for different therapeutic applications.

  • Does safety sell medicines? Does safety sell medicines?

    Who would have thought 50 years ago that thalidomide would be back on the UK market helping patients with life-threatening multiple myeloma - possible due to a risk management programme centered

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics